The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
DNA methylation analysis: a powerful new tool for lung cancer diagnosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · cited 1×
“Signatures derived from multiple genes can provide unprecedented pattern recognition, as evidenced by the recent observation that expression profiles could be used to predict clinical outcome of breast cancer patients (van’t Veer et al., 2002).”
BackgroundStatistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 8,990
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124 · cited 5×
“For more than fifteen years, it has been recognized that the methylation patterns of tumor cells are significantly altered compared to those of normal cells (reviewed by Laird, 1997; Jones and Laird, 1999; Baylin et al., 2001; Robertson, 2001; Rountree et al., 2001).”
BackgroundInfluentialEstimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
(1977) · PubMed · Cited by 1,801
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686 · cited 1×
“…be a challenge, requiring the identification of possible markers, the testing of these markers through case – control association studies and prospective trials (Sullivan Pepe et al., 2001), and the development of statistical tools to analyse complex methylation data (Siegmund and Laird, 2002).”
BackgroundAberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Belinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B., & Herman, J. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11891 · Cited by 956
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
Baylin, S. B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.687 · Cited by 929
Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
DNA methylation, methyltransferases, and cancer
Robertson, K. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204341 · Cited by 736
Prognosis and survival in resected lung carcinoma based on the new international staging system
Naruke, T., Goya, T., Tsuchiya, R., & Suemasu, K. (1988) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)35243-2 · Cited by 688
Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer‐Müller, S., Fong, K. M., Virmani, A. K., Geradts, J., Gazdar, A. F., & Minna, J. D. (2001) · PubMed · Cited by 608
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Herman, J. G., Jen, J., Merlo, A. U., & Baylin, S. B. (1996) · PubMed · Cited by 571
Hypomethylation of ras oncogenes in primary human cancers
Feinberg, A. P., & Vogelstein, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80115-6 · Cited by 514
Costello, J. F., & Plass, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.5.285 · Cited by 442
TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer
Kuramochi, M., Fukuhara, H., Nobukuni, T., Kanbe, T., Maruyama, T., Ghosh, H. P., Pletcher, M., Isomura, M., Onizuka, M., Kitamura, T., et al. (2001) · Nature Genetics · doi:10.1038/86934 · Cited by 441
DNA methylation, chromatin inheritance, and cancer
Rountree, M. R., Bachman, K. E., Herman, J. G., & Baylin, S. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204339 · Cited by 384
A Modified and Improved Method for Bisulphite Based Cytosine Methylation Analysis
Olek, A., Oswald, J., & Walter, J. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.24.5064 · Cited by 376
Agathanggelou, A., Honorio, S., Macartney, D. P., Martinez, A., Dallol, A., Rader, J., Fullwood, P., Chauhan, A., Walker, R., Shaw, J. A., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204175 · Cited by 376
Lung cancer : principles and practice
Pass, H. I. (1996) · Cited by 357
Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas
Virmani, A. K., Rathi, A., Zochbauer-Muller, S., Sacchi, N., Fukuyama, Y., Bryant, D., Maitra, A., Heda, S., Fong, K. M., Thunnissen, F., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1303 · Cited by 355
Ahrendt, S. A., Chow, J. T., Xu, L.-H., Yang, S. C., Eisenberger, C. F., Esteller, M., Herman, J. G., Wu, L., Decker, P. A., Jen, J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.332 · Cited by 345
Nuovo, G. J., Plaia, T. W., Belinsky, S. A., Baylin, S. B., & Herman, J. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12754 · Cited by 314
Tang, X. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1511 · Cited by 314
Usadel, H., Brabender, J., Danenberg, K. D., Jerónimo, C., Harden, S., Engles, J. M., Danenberg, P. V., Yang, S. S., & Sidransky, D. (2002) · PubMed · Cited by 302
CpG-Island Methylation in Aging and Cancer
Issa, J.-P. (2000) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59696-4_7 · Cited by 300
Bremner, R., & Balmain, A. (1990) · Cell · doi:10.1016/0092-8674(90)90523-h · Cited by 264
DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas.
Baylin, S. B., Höppener, J. W. M., de Bustros, A., Steenbergh, P. H., Lips, C. J. M., & Nelkin, B. D. (1986) · PubMed · Cited by 220
Methyl CpG binding proteins: coupling chromatin architecture to gene regulation
Wade, P. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204340 · Cited by 198
Du, Y., Carling, T., Fang, W., Piao, Z. H., Sheu, J., & Huang, S. (2001) · PubMed · Cited by 189
Kersting, M., Friedl, C., Kraus, A., Behn, M., Pankow, W., & Schuermann, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3221 · Cited by 181
Issa, J. J., Baylin, S. B., & Belinsky, S. A. (1996) · PubMed · Cited by 178
The H-cadherin ( CDH13 ) gene is inactivated in human lung cancer
Sato, M., Mori, Y., Sakurada, A., Fujimura, S., & Horii, A. (1998) · Human Genetics · doi:10.1007/s004390050790 · Cited by 167
Cancer Screening in Theory and in Practice
Brawley, O. W., & Kramer, B. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.107 · Cited by 157
Frequent Aberrant Methylation of p16INK4a in Primary Rat Lung Tumors
Swafford, D. S., Middleton, S. K., Palmisano, W. A., Nikula, K. J., Tesfaigzi, Y., Baylin, S. B., Herman, J. G., & Belinsky, S. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1366 · Cited by 152
DNA Methylation Analysis by MethyLight Technology
Trinh, B. N., Long, T. I., & Laird, P. W. (2001) · Methods · doi:10.1006/meth.2001.1268 · Cited by 151
Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer
Kim, D., Nelson, H. H., Wiencke, J. K., Christiani, D. C., Wain, J. C., Mark, E. J., & Kelsey, K. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204302 · Cited by 147
Beyond the genetic lesions: gene inactivation by promoter hypermethylation in human cancer
Esteller, M., Baylin, S. B., & Herman, J. G. (2000) · Revista de Oncología · doi:10.1007/bf02979467 · Cited by 139
Prostate specific antigen: biology, biochemistry and available commercial assays
Ward, A. M., Catto, J. W. F., & Hamdy, F. C. (2001) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563011901055 · Cited by 136
ELIAS, A. D. (1997) · CHEST Journal · doi:10.1378/chest.112.4_supplement.251s · Cited by 135
The Epidemiology of Lung Cancer
Williams, M. D., & Sandler, A. B. (2001) · Cancer treatment and research · doi:10.1007/978-1-4615-1589-0_2 · Cited by 130
Sánchez‐Céspedes, M., Reed, A. L., Buta, M. R., Li, W., Westra, W. H., Herman, J. G., Yang, S. C., Jen, J., & Sidransky, D. (1999) · Oncogene · doi:10.1038/sj.onc.1203003 · Cited by 130
Wolf, P., Hu, Y. C., Doffek, K. M., Sidransky, D., & Ahrendt, S. A. (2001) · PubMed · Cited by 115
Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Liloglou, T., Kyroudi, A., Veslemes, M., Rassidakis, A., Halazonetis, T. D., Field, J. K., & Kittas, C. N. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65690-8 · Cited by 113
Increased expression of unmethylated CDKN2D by 5-aza-2′-deoxycytidine in human lung cancer cells
Zhu, W., Dai, Z., Ding, H., Srinivasan, K., Hall, J., Duan, W., Villalona-Calero, M. A., Plass, C., & Otterson, G. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204970 · Cited by 106
Mechanism of Retinoblastoma Gene Inactivation in the Spectrum of Neuroendocrine Lung Tumors
Gouyer, V., Gazzéri, S., Bolon, I., Drevet, C., Brambilla, C., & Brambilla, E. M. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.2.3008 · Cited by 85
Osada, H., Tatematsu, Y., Masuda, A., Saito, T., Sugiyama, M., Yanagisawa, K., & Takahashi, T. (2001) · PubMed · Cited by 83
Oncogenic mechanisms mediated by DNA methylation
Laird, P. W. (1997) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)01019-8 · Cited by 82
浜田, 邦., Kohno, T., Kawanishi, M., Ohwada, S., & Yokota, J. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199807)22:3<232::aid-gcc9>3.0.co;2-x · Cited by 67
Hougaard, S., Nørgaard, P. H., Abrahamsen, N., Moses, H. L., Spang‐Thomsen, M., & Poulsen, H. S. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690161 · Cited by 67
Variable 5-methylcytosine levels in human tumor cell lines and fresh pediatric tumor explants.
FLATAU, E., Bogenmann, E., & Jones, P. A. (1983) · PubMed · Cited by 66
Dominant Oncogenes and Tumor Suppressor Genes in the Pathogenesis of Lung Cancer
Viallet, J., & Minna, J. D. (1990) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/2.3.225 · Cited by 64
Markl, I. D. C., Cheng, J., Liang, G., Shibata, D. K., Laird, P. W., & Jones, P. A. (2001) · PubMed · Cited by 60
Tumor p16M is a possible marker of advanced stage in non–small cell lung cancer
Ng, C. S. H., Zhang, J., Wan, S., Lee, T. W., Arifi, A. A., Mok, T. S. K., Lo, D., & Yim, A. P. C. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10046 · Cited by 58
Takai, D., Yagi, Y., Wakazono, K., Ohishi, N., Morita, Y., Sügimura, T., & Ushijima, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204940 · Cited by 56
Seike, M., Gemma, A., Hosoya, Y., Hemmi, S., Taniguchi, Y., Fukuda, Y., Yamanaka, N., & Kudoh, S. (2000) · PubMed · Cited by 52
Cancer Screening: Theory and Practice
Kramer, B. S., Gohagan, J. K., & Prorok, P. C. (2021) · CRC Press eBooks · doi:10.1201/9780429179587 · Cited by 48
Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers
Tanaka, H., Fujii, Y., Hirabayashi, H., Miyoshi, S., Sakaguchi, M., Yoon, H., & Matsuda, H. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980417)79:2<111::aid-ijc2>3.0.co;2-w · Cited by 48
Promoter Hypermethylation--Can This Change Alone Ever Designate True Tumor Suppressor Gene Function?
Baylin, S. B., & Herman, J. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.664 · Cited by 42
Marcus, D., & Kurlan, R. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70043-8 · Cited by 34
Belinsky, S. A. (1998) · Experimental Lung Research · doi:10.3109/01902149809087381 · Cited by 32
Ellis, J. R. C., & Gleeson, F. V. (2001) · British Journal of Radiology · doi:10.1259/bjr.74.882.740478 · Cited by 31
Hou, M. L., Morishita, Y., Iljima, T., Inadome, Y., Mase, K., Dai, Y., & Noguchi, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991222)84:6<609::aid-ijc12>3.0.co;2-q · Cited by 30
Cited by
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
Ehrich, M., Nelson, M. R., Stanssens, P., Zabeau, M., Liloglou, T., Xinarianos, G., Cantor, C. R., Field, J. K., & van den Boom, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507816102 · Cited by 812
High-throughput DNA methylation profiling using universal bead arrays
Bibikova, M., Lin, Z., Zhou, L., Chudin, E., Garcia, E. W., Wu, B., Doucet, D., Thomas, N. J., Wang, Y., Vollmer, E., et al. (2006) · Genome Research · doi:10.1101/gr.4410706 · Cited by 657
Gene-promoter hypermethylation as a biomarker in lung cancer
Belinsky, S. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1432 · Cited by 533
DNA Methylation, Cancer Susceptibility, and Nutrient Interactions
Davis, C. D., & Uthus, E. O. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422901002 · Cited by 390
Metadata
- Authors
- Tsou, J. A., Hagen, J. A., Carpenter, C. L., & Laird-Offringa, I. A.
- Venue
- Oncogene
- Published
- 2002-08-05
- Volume
- 21
- Issue
- 35
- Pages
- 5450-5461
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1979362779
- Cited by
- 296
- References
- 72
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.